Carregant...
Ciprofloxacin v placebo for treatment of Yersinia enterocolitica triggered reactive arthritis
Patients with yersinia triggered reactive arthritis were double blind randomly allocated to receive treatment with ciprofloxacin 500 mg twice daily orally or placebo during three months. The diagnosis was made by serology (specific IgA and IgG antibodies to yersinia outer membrane proteins (yops)),...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2000
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1753019/ https://ncbi.nlm.nih.gov/pubmed/11053072 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.59.11.914 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|